These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 11787764)
1. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs. Okabe S; Shimosako K; Amagase K J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764 [TBL] [Abstract][Full Text] [Related]
2. Antisecretory effect of leminoprazole on histamine-stimulated gastric acid secretion in dogs: potent local effect. Okabe S; Shimosako K; Harada H Jpn J Pharmacol; 1995 Oct; 69(2):91-100. PubMed ID: 8569059 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells. Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556 [TBL] [Abstract][Full Text] [Related]
4. [New target for the inhibitors of gastric acid secretion. Inhibition of myosin and actin activities via the apical membrane of parietal cells in dogs]. Okabe S; Fujishita T; Jinbo K Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():74P-77P. PubMed ID: 14727528 [TBL] [Abstract][Full Text] [Related]
5. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents. Palumbo GJ; Nielsen ST Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole. Batzri S; Brugada O; Harmon JW; Rich NM J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448 [TBL] [Abstract][Full Text] [Related]
8. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro. Wallmark B; Lorentzon P; Larsson H Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109 [TBL] [Abstract][Full Text] [Related]
9. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936 [TBL] [Abstract][Full Text] [Related]
10. Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs. Katz LB; Tobia AJ; Shriver DA J Pharmacol Exp Ther; 1987 Aug; 242(2):437-42. PubMed ID: 2886642 [TBL] [Abstract][Full Text] [Related]
11. Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat. Kato S; Aihara E; Yoshii K; Takeuchi K Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G64-9. PubMed ID: 15961884 [TBL] [Abstract][Full Text] [Related]
12. Effects of acid-degraded products of leminoprazole on acid secretion, mucus secretion and synthesis, and indomethacin-induced damage in cell culture. Takahashi S; Tsukahara T; Okabe S J Physiol Pharmacol; 1998 Mar; 49(1):99-110. PubMed ID: 9594414 [TBL] [Abstract][Full Text] [Related]
13. Current status of acid pump antagonists (reversible PPIs). Wurst W; Hartmann M Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692 [TBL] [Abstract][Full Text] [Related]
14. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats. Amagase K; Kato S; Yamamoto H; Okabe S Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310 [TBL] [Abstract][Full Text] [Related]
15. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418 [TBL] [Abstract][Full Text] [Related]
16. Effects of the new H2-receptor antagonist 3-amino-4-[4- [4- (1-piperidinomethyl)-2-pyridyloxy]-cis-2-butenylamino]-3-cyclobutene-1, 2- dione hydrochloride on gastric acid secretion and ulceration. Muramatsu M; Isobe Y; Arai I; Hirose-Kijima H; Usuki-Ito C; Nagai H; Aihara H; Otomo S Arzneimittelforschung; 1990 Jan; 40(1):49-54. PubMed ID: 1971169 [TBL] [Abstract][Full Text] [Related]
17. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine. Katz LB; Scott CK; Shriver DA J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172 [TBL] [Abstract][Full Text] [Related]
18. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine. Cavanagh RL; Usakewicz JJ; Buyniski JP J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316 [TBL] [Abstract][Full Text] [Related]
19. Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats. Isobe Y; Nagai H; Muramatsu M; Aihara H; Otomo S J Pharmacol Exp Ther; 1990 Dec; 255(3):1078-82. PubMed ID: 1979811 [TBL] [Abstract][Full Text] [Related]
20. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs. Takagi T; Takeda M; Maeno H Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]